International Conference on

Parkinsons and Neurodegenerative diseases

December 02-03, 2019 Dubai, UAE

Theme: A Strong Determination to Evolve Advanced Medication

About Conference

Conference Series LLC LTD proudly presents International Conference on Parkinson’s and Neurodegenerative diseases. We invite participants around the world to Dubai, UAE for Parkinson's 2019 held during December 02-03, 2019.

Parkinson's deals with Neurological Syndromes caused due to leakage of electric impulse in neurons which leads to loss of communication. This kind of medical conditions are getting frequent in humans at present situations. It has been observed there are number of diseases associated with Neurological disorders for examples Parkinson’s diseases, Huntington’s, Alzheimer’s disease, brain tumours, Multiple Sclerosis, Spinal Muscular Atrophy, Brain Stroke, Epilepsy, Amyotrophic Lateral Sclerosis.

According to current survey Neurological disorders occupy first place in Europe Brain disorders are like Brain Tumour, Cerebral palsy, chiari malformation, Craniofacial abnormalities, Craniosynostosis, Developmental disorders, Encephalopathy, Epilepsy are recognized by World Health Organization in Europe. It is been identified 1.2 million people in Europe are suffering with Parkinson’s approximately 260000 people in Germany, 200000 people in Italy, 150000 people in Spain, 120000 people in UK, 117000 people in France are suffering from Parkinson's disease.

World Health Organization (WHO) and World Federation of Neurology (WFN) were collaborated after find the rate of Neurological disorders worldwide. An international Survey of Country Resources for Neurological disorders effects 109 countries and covering over 90% of the world’s population. This survey helps to collect valuable information regarding aspects of neurological care all around the world.

At National Institute of Health funding package is of $34 billion for the economic year 2017 to improve life of patients who are suffering from Parkinson’s disease and to raise the awareness on Neurological disorders around the World. PRP (Parkinson's Research Program) fund received amount of $16 million annually to research in neuromuscular disorders such as Alzheimer’s, Parkinson’s disease & Huntington’s disease.

Why to attend?

International Conference on Parkinson’s and Neurodegenerative diseases provides best plat form for Neurologists, Neurosurgeons, Scientists, Clinical Industry Specialists, Neurology Experts, Young Researchers with an aim to make patients feel better with innovative research outcomes.

Target audience:

Neuro physicians, Neruo surgeons, Neurologists, Psychiatrist, Physiotherapists, Neruo Specialists, Researchers, Professors, Industrials Experts, Nutritional Scientists, Lecturers and Students from Academic study in Parkinson’s and Huntington’s diseases , Pharma researchers on Neurology and Neuroscience, Therapists and Diagnostic Experts.